Search Results - "Michel, Auguet"

Refine Results
  1. 1

    Different antinociceptive effects of botulinum toxin type A in inflammatory and peripheral polyneuropathic rat models by Favre-Guilmard, Christine, Auguet, Michel, Chabrier, Pierre-Etienne

    Published in European journal of pharmacology (01-09-2009)
    “…In addition to inhibition of acetylcholine release in the neuromuscular junction botulinum toxin type A (BoNT-A) also inhibits the release of mediators…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Induction of nitric oxide synthase by lipoteichoic acid from Staphylococcus aureus in vascular smooth muscle cells by Auguet, Michel, Lonchampt, Marie-Odile, Delaflotte, Sylvie, Goulin-Schulz, Jocelyne, Chabrier, Pierre Etienne, Braquet, Pierre

    Published in FEBS letters (03-02-1992)
    “…Inducible vascular nitric oxide synthase accounts for the contractile impairment observed in ondotoxemia. We provide evidence that lipoteichoic acid (LTA) from…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Novel azoles as potent and selective cannabinoid CB2 receptor agonists by Harnett, Jeremiah J., Dolo, Christine, Viossat, Isabelle, Auger, Florence, Ferrandis, Eric, Bigg, Dennis, Auguet, Michel, Auvin, Serge, Chabrier, Pierre-E.

    Published in Bioorganic & medicinal chemistry letters (01-01-2015)
    “…[Display omitted] Novel azole compounds were prepared which demonstrated potent hCB2 binding activities with antioxidant activity for a selected compound…”
    Get full text
    Journal Article
  9. 9
  10. 10

    BN82451 attenuates l-dopa-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson’s disease by Spinnewyn, Brigitte, Mautino, Gisele, Marin, Jean-Gregoire, Rocher, Marie Noëlle, Grandoulier, Anne Sophie, Ferrandis, Eric, Auguet, Michel, Chabrier, Pierre-Etienne

    Published in Neuropharmacology (01-03-2011)
    “…The development of l-dopa-induced dyskinesia (LID) remains a major problem in the long-term treatment of Parkinson’s disease (PD). This study aimed to assess…”
    Get full text
    Journal Article
  11. 11

    Analgesic effects of Botulinum toxin A in an inflammatory pain model in rats: Comparison of Dysport ® and Botox ®; synergistic interaction with morphine by Michel, Auguet, Christine, Favre-Guilmard, Pierre-Etienne, Chabrier

    Published in Toxicon (Oxford) (01-06-2008)
    “…The analgesic effect of Botulinum toxin A has been already demonstrated in different experimental models of pain. The aim of the present study was to compare…”
    Get full text
    Journal Article
  12. 12

    Analgesic properties of botulinum toxin type A (Dysport ®) in paclitaxel-induced peripheral neuropathy in rats by Christine, Favre-Guilmard, Michel, Auguet, Pierre-Etienne, Chabrier

    Published in Toxicon (Oxford) (01-06-2008)
    “…Botulinum toxin type A has been shown to elicit direct analgesic effect independent of anti-spastic activity. We have assessed the analgesic effect of a single…”
    Get full text
    Journal Article
  13. 13
  14. 14

    An improved model to investigate the efficacy of antidyskinetic agents in hemiparkinsonian rats by Spinnewyn, Brigitte, Charnet, Christelle, Cornet, Sylvie, Roubert, Véronique, Chabrier, Pierre-Etienne, Auguet, Michel

    Published in Fundamental & clinical pharmacology (01-10-2011)
    “…A number of experimental models of L‐DOPA‐induced dyskinesia have been proposed, but these models result in a low to medium rate of dyskinetic animals with…”
    Get full text
    Journal Article
  15. 15

    Endothelium independent protective effect of NG-monomethyl-L-arginine on endotoxin-induced alterations of vascular reactivity by Auguet, M, Guillon, J M, Delaflotte, S, Etiemble, E, Chabrier, P E, Braquet, P

    Published in Life sciences (1973) (1991)
    “…The effects of NG-monomethyl-L-arginine (NMMA), a specific inhibitor of nitric oxide (NO) synthesis was tested on the endotoxin-induced alterations of…”
    Get more information
    Journal Article
  16. 16

    Selective Inhibition of Inducible Nitric Oxide Synthase by Agmatine by Auguet, Michel, Viossat, Isabelle, Marin, Jean-Gregoire, Chabrier, Pierre-Etienne

    Published in Japanese Journal of Pharmacology (1995)
    “…Agmatine was about as potent as aminoguanidine to inhibit the activity of the inducible form of nitric oxide synthase (iNOS) in isolated rat aorta. Like…”
    Get full text
    Journal Article
  17. 17

    The novel inhibitor of the heterotrimeric G-protein complex, BIM-46187, elicits anti-hyperalgesic properties and synergizes with morphine by Favre-Guilmard, Christine, Zeroual-Hider, Hamida, Soulard, Chantal, Touvay, Caroline, Chabrier, Pierre-Etienne, Prevost, Grégoire, Auguet, Michel

    Published in European journal of pharmacology (10-10-2008)
    “…BIM-46187 (7-[2-amino-1-oxo-3-thio-propyl]-8-cyclohexylmethyl-2-phenyl-5,6,7,8-tetrahydro-imidazo-[1,2a]-pyrazine dimer, hydrochloride) is an inhibitor of the…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Lack of evidence of direct mitochondrial involvement in the neuroprotective effect of minocycline by Cornet, Sylvie, Spinnewyn, Brigitte, Delaflotte, Sylvie, Charnet, Christelle, Roubert, Véronique, Favre, Christine, Hider, Hamida, Chabrier, P. Etienne, Auguet, Michel

    Published in European journal of pharmacology (28-11-2004)
    “…Minocycline has been reported to exert neuroprotection through inhibition of inflammatory processes and of mitochondrial cell death pathway. To further…”
    Get full text
    Journal Article
  20. 20

    Novel lipoic acid analogues that inhibit nitric oxide synthase by Harnett, Jeremiah J, Auguet, Michel, Viossat, Isabelle, Dolo, Christine, Bigg, Dennis, Chabrier, Pierre-E

    Published in Bioorganic & medicinal chemistry letters (03-06-2002)
    “…The synthesis and biological activity of novel lipoic acid analogues are reported. Lipoic acid and structural homologues coupled to arylthiophene amidine via…”
    Get full text
    Journal Article